Benevir Biopharm

Benevir Biopharm

Benevir Biopharm

In the emerging field of oncolytic virotherapy, BeneVir is developing an improved therapeutic platform that can be adapted to target a wide variety of cancers.
Founded
2011
Raised
$5M
Follow us
Alexa global traffic share